CAS 59703-84-3|Piperacillin Sodium
Introduction：Basic information about CAS 59703-84-3|Piperacillin Sodium, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Piperacillin Sodium | ||
|---|---|---|---|
| CAS Number | 59703-84-3 | Molecular Weight | 539.537 |
| Density | / | Boiling Point | 707.1ºC at 760 mmHg |
| Molecular Formula | C23H26N5NaO7S | Melting Point | 183-185ºC (dec.) |
| MSDS | ChineseUSA | Flash Point | 381.4ºC |
Names
| Name | piperacillin sodium |
|---|---|
| Synonym | More Synonyms |
Piperacillin Sodium BiologicalActivity
| Description | Piperacillin sodium is a broad-spectrum β-lactam antibiotic. |
|---|---|
| Related Catalog | Signaling Pathways >>Anti-infection >>BacterialResearch Areas >>Infection |
Chemical & Physical Properties
| Boiling Point | 707.1ºC at 760 mmHg |
|---|---|
| Melting Point | 183-185ºC (dec.) |
| Molecular Formula | C23H26N5NaO7S |
| Molecular Weight | 539.537 |
| Flash Point | 381.4ºC |
| Exact Mass | 539.145081 |
| PSA | 184.56000 |
| Index of Refraction | 180 ° (C=0.8, H2O) |
| InChIKey | WCMIIGXFCMNQDS-IDYPWDAWSA-M |
| SMILES | CCN1CCN(C(=O)NC(C(=O)NC2C(=O)N3C2SC(C)(C)C3C(=O)[O-])c2ccccc2)C(=O)C1=O.[Na+] |
| Storage condition | Store at 0-5°C |
| Water Solubility | H2O: 50 mg/mL, clear, colorless to faintly yellow |
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R42/43 |
| Safety Phrases | S22-S36/37-S45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | XI0180000 |
Articles41
More Articles| Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation. Clin. Chem. Lab Med. 53(5) , 781-91, (2015) Recent studies have demonstrated highly variable blood concentrations of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in critically ill patients with a high incidence of ... | |
| Gingival pain: an unusual side effect of ziprasidone. BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013) The patient is a 52-year-old man with schizophrenia who developed severe, unremitting gingival pain after his ziprasidone dosage was increased from 80 to 120 mg. His physical examination and laborator... | |
| The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*. Crit. Care Med. 42(7) , 1640-50, (2014) To describe the effect of different renal replacement therapy modalities and settings on the clearance of meropenem, piperacillin, and vancomycin in critically ill patients and to evaluate the frequen... |
Synonyms
| (2S-(2a,5a,6b(S*)))-6-(((((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Monosodium Salt |
| EINECS 261-868-6 |
| Sodium (2S,5R,6R)-6-((R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate |
| Sodium (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
| 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt, (2S,5R,6R)- (1:1) |
| Sodium (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
| Piperacillin sodium salt |
| Natrium-(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylat |
| Sodium (2S,5R,6R)-6-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
| MFCD00917471 |
| 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, (2S,5R,6R)- |
| (2S,5R,6R)-6-{[(2R)-2-{[(4-éthyl-2,3-dioxopipérazin-1-yl)carbonyl]amino}-2-phénylacétyl]amino}-3,3-diméthyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate de sodium |
| Piperacillin (sodium) |
